Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FJGFL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,389
Award facts
- Contract value 100% obligated
- $1,388.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Nexplanon 68 mg implants valued at $1,388.64. The award, issued on July 30, 2025, is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025. No set-aside designation was used in this procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, delivering prescription medications, biologics, and medical consumables directly to Department of Defense healthcare sites. The company has maintained a robust contract portfolio with the DLA since its SAM.gov registration in 2001, securing multiple delivery orders for varied pharmaceutical products including contraceptive devices, oncology treatments, vaccines, and specialty medications. The Nexplanon implants covered under this delivery order represent a routine procurement from the contractor's extensive pharmaceutical product offerings to support federal healthcare system needs.
Quick answers
Who was awarded contract SPE2DB25FJGFL?
SPE2DB25FJGFL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FJGFL worth?
The government has obligated $1,389 on SPE2DB25FJGFL.
Is contract SPE2DB25FJGFL an order under another contract?
Yes. SPE2DB25FJGFL is a delivery order under SPE2DB24D9224, an indefinite delivery contract.
Was contract SPE2DB25FJGFL competed?
The extent of competition for SPE2DB25FJGFL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award